R18 z-644282 GDC-0941 sensitizes breast cancer to

GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1

is an orally bioavailable estradiol metabolite with potential antineoplastic activity

The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635

Imiclopazine is a phenothiazine derivative with good sedative

InChi: InChI=1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2

R18 z-644282 GDC-0941 sensitizes breast cancer toR18 is a peptide antagonists of 14 3 3, with a KD of 70 90 nM. R18 efficiently blocks the binding of 14 3 3 to the kinase Raf 1, a physiological ligand of 14 3 3, and effectively abolished the protective role of 14 3 3 against phosphatase induced inactivation of Raf 1. Product information CAS Number: 211364 78 2 Molecular Weight: 1972. 29 Formula: C87H138N22O26S2 Chemical Name: 1 [2 (2 {2 [2 (2 {2 [2 (2 {2 [2 (2 {2 [2 (2 {[1 (2 amino 3